Systemic candidiasis in intensive care units: A multicenter, matched-cohort study

Journal of Critical Care

Volumn 17, Issue 3, 2002, Pages 168-175

  Leleu, Ghislaine ^a,b,c,d   Aegerter, Philippe ^a,b,c,d   Guidet, Bertrand ^a,b,c,d  

^a Collège Des Utilisateurs De Base De Données En Réanimation ^*  (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; SYSTEMIC MYCOSIS;

EID: 0036741450     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcrc.2002.35815     Document Type: Article

References (31)

1. Edwards JR Jr: Invasive candida infections. Evolution of a fungal pathogen. N Engl J Med 324:1060-1062, 1991
2. Beck-Sagué C, Jarvis WR: Secular trends in the epidemiology of fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 167:1247-1251, 1993
3. Voss A, Kluytmans JA, Koeleman JG, et al: Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 15:909-912, 1996
4. Vincent JL, Bihari DJ, Sutter PM, et al: The prevalence of nosocomial infection in Intensive Care Units in Europe results of the European Prevalence Infection in Intensive Care (EPIC) Study. JAMA 274:639-644, 1995
5. Jarvis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526-1530, 1995
6. Edmond MB, Wallace SE, McClish DK, et al: Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 29:239-244, 1999
7. Fridkin SK, Jarvis WR: Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9:499-511, 1996
8. Rentz AM, Halpern MT, Bowden R: The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 27:781-788, 1998
9. Wey SB, Mori M, Pfaller M, et al: Hospital-acquired candidaemia. The attributable mortality and excess length of stay. Arch Intern Med 148:2642-2645, 1988
10. Nolla-Salas J, Sitges-Serra A, Léon-Gil C, et al: Candidaemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 23:23-30, 1997
11. Pittet D, Li N, Woolson RF, et al: Microbiological factors influencing the outcome of nosocomial bloodstream infections. A 6-year validated, population-based model. Clin Infect Dis 24:1068-1078, 1997
12. Karabinis A, Hill C, Leclercq B, et al: Risk factors for candidemia in cancer patients: A case control study. J Clin Microbiol 26:429-432, 1988
13. Abi-Said D, Anaissie E, Uzun O, et al: The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122-1128, 1997
14. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al: National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29:253-258, 1999
15. Blumberg HM, Jarvis WR, Soucie JM, et al: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. Clin Infect Dis 33:177-186, 2001
16. Bone RC, Fein AM, Balk RA, et al and The ACCP/SCCM Consensus Conference Committee: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992
17. Aegerter Ph, Auvert B, Buonamico G, et al: Mise en oeuvre et évaluation d'une base de données commune aux services de réanimation d'Ile-de-France. Rev Epidemio Santé Publ 46:226-237, 1998
18. Sznajder M, Leleu G, Buonamico G, et al: Estimation of direct cost and resource allocation in intensive care: Correlation with Omega system. Intensive Care Med 24:582-589, 1998
19. Sznajder M, Aegerter Ph, Launois R, et al: A cost-effectiveness approach of stays in intensive care units. Intensive Care Med 27:146-153, 2001
20. Commission d'évaluation de la SRLF: Utilisation de l'indice de gravité simplifié et du système Omega. Mise à jour 1986. Réa Soins Intens Méd Urg 2:219-221, 1986
21. Gruppo Italiano Ricerche in Terapia Intensiva: Efficienza di utilizzo delle risorse impiegate in reparti di terapia intensiva di area urbana. Minerva Anestesiol 57:103-110, 1991
22. Kleinbaum DG, Kupper LL, Morgenstern H: Category matching: validity and efficiency, in Kleinbaum DG, Kupper LL, Morgenstern H (eds): Epidemiologic research. Principles and quantitative methods. New York, Van Nostrand Reinhold, 1982, pp 384-389
23. Mc Cabe WR, Jackson GG: Gram-negative bacteremia. Arch Intern Med 110:847-855, 1962
24. Vincent JL, Anaissie E, Bruining H, et al: Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206-216, 1998
25. Voss A, le Noble JL, Verduyn Lunel FM, et al: Candidaemia in intensive care units: Risk factors for mortality. Infection 25:8-11, 1997
26. Wingard JR, Metz WG, Rinaldi MG, et al: Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325:1274-1277, 1991
27. Viscoli C, Girmenia C, Marinus A, et al: Candidaemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28:1071-1079, 1999
28. Nguyen MH, Peacock JE Jr, Morris AJ, et al: The changing face of candidaemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 100:617-623, 1996
29. Pfaller MA, Jones RN, Doern GV, et al: International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program. J Clin Microbiol 36:1886-1889, 1998
30. Fraser VJ, Jones M, Dunkel J, et al: Candidaemia in a tertiary care hospital: Epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15:414-421, 1992
31. Pittet D, Monod M, Suter PM, et al: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758, 1991